| |MAY 20239Motherhood Hospitals, which operates 21 hospitals in ten cities, has implemented a novel remote patient monitoring technology and system to provide virtual life-saving neonatal care to newborns admitted to nursing homes and hospitals in semi-urban and rural areas that lack proper Neonatal Intensive Care Units (NICU). Neonatal care, which provides newborns with life-saving clinical care, is regarded as one of the most clinically demanding services in healthcare, and Motherhood Hospitals NICU is no exception. Live solution is assisting in the transformation of this service to newborns in rural areas by utilising neonatal telehealth technologies supported by a team of highly experienced neonatologists and nurses across multiple locations, thereby creating a network of virtual neonatal intensive care units. Critically ill newborn babies are monitored remotely using cutting-edge technology.NICU Live treats high-risk newborns admitted to distant NICUs using cutting-edge remote monitoring technology and a specialised digital solution. In the first phase of this groundbreaking initiative, Motherhood Hospitals established a central care centre or hub that is linked to five remote NICUs in Anantapur, Hindupur, Madanapalle, Patna, and Hisar.The hub-and-spoke model is based on full-time patient management and round-the-clock medical support. The central care team (hub) provides 24/7 monitoring and treatment support to the remote NICU (spoke) centres via high-resolution PTZ cameras with live video feed, a digital platform that ensures all critical information is shared digitally, and a constant communication link between the teams, resulting in significantly improved medical outcomes for these newborns. Furthermore, the experienced team of neonatologists and NICU nurses provide regular upskilling and training on NICU treatment modalities to the spoke centre care team. POOlder people and those with weakened immune systems may be given a second dose of Omicron-targeting COVID-19 vaccines, according to the Centres for Disease Control and Prevention (CDC). The agency's decision follows the FDA's approval on Tuesday of a second dose of Omicron-updated booster for the specified high-risk population. Adults 65 and older can receive a second dose of the updated vaccine, according to the CDC, while people with compromised immune systems can receive additional doses. The original COVID-19 vaccine will also no longer be recommended for use in the United States, according to the statement. On Tuesday, the FDA also announced that the updated shots from Pfizer/BioNTech and Moderna would become the primary COVID vaccine. It revoked its emergency-use authorization for older messenger RNA vaccines that only target the original coronavirus. The changes made today did not affect monovalent COVID-19 vaccines from Novavax or Johnson & Johnson's Janssen, according to the agency.In February, a working group of CDC advisers concluded that there was insufficient evidence to recommend more than one COVID-19 booster shot per year for the specified population, but they did support flexibility in recommendations for the immunocompromised population to receive more frequent doses. POVIRTUAL NEONATAL INTENSIVE CARE UNIT AT MOTHERHOOD HOSPITALS TO BRIDGE THE GAP BETWEEN RURAL & URBAN INDIAUS CDC APPROVES SECOND OMICRON-UPDATED COVID BOOSTER FOR ADULTS
< Page 8 | Page 10 >